-+ 0.00%
-+ 0.00%
-+ 0.00%
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Share
Listen to the news

Gainers

  • KalVista Pharmaceuticals (NASDAQ:KALV) shares rose 38.5% to $26.66 during Wednesday's pre-market session. The company's market cap stands at $985.5 million.
  • GlucoTrack (NASDAQ:GCTK) stock increased by 26.64% to $1.06.
  • Akanda (NASDAQ:AKAN) stock increased by 16.52% to $20.38. The market value of their outstanding shares is at $9.3 million.
  • NeoGenomics (NASDAQ:NEO) shares increased by 14.19% to $10.3. The market value of their outstanding shares is at $1.1 billion. The company's, Q1 earnings came out yesterday.
  • Icon (NASDAQ:ICLR) shares rose 14.15% to $117.0. The company's market cap stands at $7.8 billion.
  • Traws Pharma (NASDAQ:TRAW) stock rose 12.39% to $1.36. The market value of their outstanding shares is at $12.2 million.

Losers

  • BiomX (AMEX:PHGE) shares fell 18.6% to $0.7 during Wednesday's pre-market session. The market value of their outstanding shares is at $7.5 million.
  • CollPlant Biotechnologies (NASDAQ:CLGN) shares declined by 12.95% to $0.34. The company's market cap stands at $4.9 million.
  • China Pharma Holding (AMEX:CPHI) shares fell 11.35% to $0.5. The company's market cap stands at $2.8 million.
  • GE HealthCare Techs (NASDAQ:GEHC) shares fell 10.26% to $61.48. The market value of their outstanding shares is at $31.2 billion. As per the news, the Q1 earnings report came out today.
  • Intellia Therapeutics (NASDAQ:NTLA) stock decreased by 9.1% to $12.0. The company's market cap stands at $1.5 billion.
  • Onconetix (NASDAQ:ONCO) shares declined by 8.99% to $0.7. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending